Elevated TGFβ–Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease
- 13 May 2010
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 222 (1) , 21-31
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is a common inherited renal disease characterized by many fluid‐filled cysts and interstitial fibrosis in the kidneys, leading to chronic renal failure. During cystogenesis the renal tubules undergo extensive structural alterations that are accompanied by altered cellular signalling, directly and/or indirectly regulated by the PKD1 and PKD2 proteins. Since transforming growth factor (TGF)‐β signalling modulates cell proliferation, differentiation, apoptosis, adhesion and migration of various cell types, we studied the activation of this signalling pathway in Pkd1‐mutant mouse models at different stages of the disease. Therefore, we analysed expression of the TGFβ–Smad signalling pathway and its target genes in different Pkd1 mutant mouse models in various stages of polycystic disease. Nuclear accumulation of P‐Smad2 in cyst lining epithelial cells was not observed in the initiation phase but was observed at mild and more advanced stages of PKD. This coincides with mild fibrosis and increased mRNA levels of TGFβ target genes, such as fibronectin, collagen type I, plasminogen activator inhibitor 1 and matrix metalloproteinase‐2. At this stage many interstitial fibroblasts were found around cysts, which also showed nuclear localization for P‐Smad2. However, bone morphogenetic protein (BMP) signalling, which can antagonize TGFβ signalling, is not affected, since nuclear expression of P‐Smad1/5/8 and expression of the BMP target gene, inhibitor of DNA binding/differential‐1 (ID‐1) is not altered compared to wild‐type controls. Also, human kidneys with progressive ADPKD showed increased nuclear localization of P‐Smad2, while in general expression of P‐Smad1/5/8 was weak. These results exclude TGFβ signalling at the initiation of cystogenesis, but indicate an important role during cyst progression and in fibrogenesis of progressive ADPKD. Copyright © 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
Funding Information
- Polycystic Kidney Disease Research Foundation (175G08a)
- Dutch Kidney Foundation
- Netherlands Organization for Scientific Research (NWO/ZonMw 917.36.353)
- Centre for Biomedical Genetics
This publication has 52 references indexed in Scilit:
- Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networksHuman Molecular Genetics, 2009
- TGF-β Mediated Epithelial-Mesenchymal Transition in Autosomal Dominant Polycystic Kidney DiseaseYonsei Medical Journal, 2009
- Interleukin-20 targets renal cells and is associated with chronic kidney diseaseBiochemical and Biophysical Research Communications, 2008
- Quantification of Cre-mediated recombination by a novel strategy reveals a stable extra-chromosomal deletion-circle in miceBMC Biotechnology, 2008
- Control of matrix metalloproteinase catalytic activityMatrix Biology, 2007
- Gene profiling of polycystic kidneysNephrology Dialysis Transplantation, 2006
- Lowering of Pkd1 expression is sufficient to cause polycystic kidney diseaseHuman Molecular Genetics, 2004
- Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-β-induced fibronectin in mesangial cellsBiochemical and Biophysical Research Communications, 2002
- Fibronectin synthesis by human tubular epithelial cells in culture: Effects of PDGF and TGF-β on synthesis and splicingKidney International, 1998
- New mouse model for polycystic kidney disease with both recessive and dominant gene effectsKidney International, 1995